10 / July / 2026 Cancer treatments advance, but clinical trials lack diversity Most drugs are tested on populations from wealthy countries—expanding participation to other regions could make therapies more effective for different patient profiles Por Gabriela Monteiro
09 / July / 2026 Study identifies clues to distinguish benign tumor from salivary gland cancer Analysis of atypical cases suggests that cellular markers may help distinguish Warthin tumor from mucoepidermoid carcinoma Por Arthur Almeida
16 / June / 2026 Electroacupuncture may help treat chemotherapy-induced pain Phase 3 study presented at the ASCO Annual Meeting evaluates the technique as a nonpharmacological alternative for peripheral neuropathy in cancer patients Por Samuel Antenor
10 / June / 2026 Cancer clinical trials grow more slowly than expected in Brazil, study finds A 20-year analysis shows that the country has made progress but still faces regulatory and cultural barriers, as well as reliance on the pharmaceutical industry. Por Gabriela Monteiro
03 / June / 2026 Daraxonrasib: the story of a drug that took 44 years to develop A New York Times report chronicles four decades of research culminating in the development of daraxonrasib, a drug that doubled the overall survival of patients with metastatic pancreatic cancer Por Diogo Rodriguez
02 / June / 2026 Pancreatic cancer: Oral drug almost doubles survival in clinical trial Data presented at ASCO 2026 showed that daraxonrasib reduced the risk of death by 60% in patients with metastatic pancreatic cancer Por Daniel Dieb
29 / May / 2026 Leukemia caused by a virus transmitted through breastfeeding could be prevented with maternal screening With incidence rates up to 32 times higher among Caribbean immigrants and cases often mistaken for other lymphomas, ATLL is an underrecognized disease for which Japan now has prevention measures Por Gilberto Stam
24 / February / 2026 Breast cancer, science, and autonomy: Why read Quando a Vida Pede Coragem Historian transforms her experience with cancer into a critical reflection on evidence-based medicine, information overload, and patient agency. Por Bruno de Pierro
23 / May / 2025 The frontiers of cancer treatment New inhibitors revolutionize cancer treatment, but tumor cell resistance demands a different approach Por Julia Rezende da Silva
04 / April / 2025 Using the immune system to fight brain cancer Research reveals that immune cells modified with CAR and cytokine have the potential to cure up to 67% of mice with glioblastoma, paving the way for new treatments Por Gilberto Stam
